Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 10361

By using insights from one job to help it do another, a successful new artificial intelligence hints at a more versatile future for machine learning.

Backstory: Most algorithms can be trained in only one domain, and can’t use what’s been learned for one task to perform another, new one. A big hope for AI is to have systems take insights from one setting and apply them elsewhere—what’s called transfer learning.

What’s new: DeepMind built a new AI system called IMPALA that simultaneously performs multiple tasks—in this case, playing 57 Atari games—and attempts to share learning between them. It showed signs of transferring what was learned from one game to another.

Read more

New targeted cancer therapies have emerged to fight tumors, and scientists have much more in the pipeline.

Summary: New targeted cancer therapies have been highlighted this month as emerging technologies to fight tumors, and scientists have much more in the pipeline. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Targeted cancer therapies – the most famous of which are immunotherapies such as CAR T-cell therapy – are the current focus of excitement in cancer treatment. New therapies and developments in the immunotherapy field prompted the National Cancer Institute (NCI) to update their guidance on targeted cancer therapies a little over a week ago. As the NCI says.

“Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer.”

Continue reading “Breakthroughs in Targeted Cancer Therapies to Fight Tumors” | >

Summary: Cancer immunotherapy treatments and other approaches to cure nearly all cancers within 8 years says Dr. Gilliland, a prominent cancer research head. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Gary Gilliland, M.D., Ph.D. is the President and Director, Fred Hutchinson Cancer Research Center and in an opinion piece published at the beginning of this month, writes.

“I’ve gone on record to say that by 2025, cancer researchers will have developed curative therapeutic approaches for most if not all cancers.”

Read more